• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    State of the Industry Series (Part 1): FDA Restructuring and FTC Activity

    State of the Industry Part 2: Supplement Access, Safety, and CBD

    State of the Industry Part 3: Communication, Education, and Trust

    State of the Industry Part 4: Advanced/Advancing Technologies and Research

    State of the Industry Part 5: Advocating Best Practices
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier
    Exclusives
    Top Companies
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    Tocotrienol Supplementation May Aid Liver Function in Diabetes, MASL Patients

    Euromed Receives EcoVadis Platinum Medal for ESG Efforts

    State of the Industry Part 2: Supplement Access, Safety, and CBD
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Kyowa Hakko Publishes First Report on Global Health, Sustainability Impact
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    MSM Linked to Improvements in Knee Pain

    Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress

    NutraShure Introduces SA3X as Exclusive US Supplier

    NPA Lawsuit Claims New York Age Restriction on Supplements is Unconstitutional

    Gencor’s PEA Ingredient Levagen+ May Offer Allergy Relief
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Xsto Solutions

    Botanic Healthcare LLC

    Premium Labels & Packaging Solutions

    American FlexPack

    PLT Health Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Xsto Solutions

    Botanic Healthcare LLC

    Premium Labels & Packaging Solutions

    American FlexPack

    PLT Health Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Top Companies
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Study Demonstrates Safety of Sustained Niagen Supplementation & Optimal Dose

    Data will be used to design trials that test the activity of Niagen against diseases and conditions of metabolic stress.

    Study Demonstrates Safety of Sustained Niagen Supplementation & Optimal Dose
    07.08.19
    The largest clinical trial to date on nicotinamide riboside (NR), according to ChromaDex Corp., further validated the safety and efficacy of the company’s proprietary form of NR, Niagen. Results were was published in the journal Scientific Reports.
     
    “The results of this large human trial directly support the efficacy and safety of our NAD-boosting consumer product Tru Niagen,” said ChromaDex CEO Rob Fried. “The study also provides key data points for regulatory submissions as we continue our global expansion.”
     
    This is the first clinical trial to measure both the kinetics and dose-dependent effects of chronic Niagen supplementation, according to the company; 132 healthy overweight adults completed the randomized, double-blind, placebo-controlled, parallel arm trial. The results showed how supplementation with three different daily doses of Niagen (100 mg, 300 mg, 1,000 mg) initially increase and then sustain elevated blood NAD levels over the course of an 8-week period.
     
    The results of this study support the NAD-boosting efficacy of Tru Niagen, which recommends a daily serving size of 300 mg in the U.S. On average, study participants consuming 300 mg/day experienced a statistically significant 51% increase in whole blood NAD+ within two weeks. This increase was maintained throughout the remainder of the eight-week study.
     
    The study also joins previous chronic supplementation studies to support the safety of chronic Niagen supplementation. All doses tested were well-tolerated with no attributable adverse events reported. By the end of the eight-week trial, no changes in LDL cholesterol levels or blood levels of homocysteine were observed. These results further differentiate Niagen from other NAD-boosting supplements and support the establishment of a unique upper limit for Niagen versus other B3 vitamins, the company said.
     
    “This is a timely publication in the history of Niagen as it clearly shows safe, dose-dependent and time-dependent increases in blood NAD in human populations,” said Charles Brenner, PhD, Roy J. Carver Chair & Head of Biochemistry at the University of Iowa & ChromaDex chief scientific advisor. “With so much global interest in NAD-boosting supplementation strategies, our approach to human translation has been to put safety first. These data will be used to design the next generation of trials to promote wellness as well as to test the activity of Niagen against diseases and conditions of metabolic stress.”
     
    “This clinical study builds upon a body of research demonstrating the safe and sustained benefits of Niagen supplementation, and importantly identifies optimal dosing to achieve increased NAD levels over time,” said Matthew Roberts, PhD, chief scientific officer, ChromaDex. 
     
    To date, ChromaDex has invested millions of dollars in safety and human clinical trials on its patent-protected NR (commercially known as Niagen) and has entered research agreements with more than 160 institutions for research, including Dartmouth, the National Institutes of Health, University of Iowa, and the Scripps Research Institute.
     
    NIAGEN is the only commercially available nicotinamide riboside which has twice been reviewed under FDA's new dietary ingredient (NDI) notification program and has also been successfully notified to the FDA as generally recognized as safe (GRAS).
    Related Searches
    • fda
    • Regulatory
    • overweight
    • clinical study
    Related Knowledge Center
    • Vitamins
    • Healthy Aging
    • Research
    Suggested For You
    EAS Assists Food & Hemp Firms with GRAS Submissions EAS Assists Food & Hemp Firms with GRAS Submissions
    Preparing for FDA’s New Era of Food Safety Preparing for FDA’s New Era of Food Safety
    Engaging Doctors in the Dialogue About ‘DSHEA 2.0’ Engaging Doctors in the Dialogue About ‘DSHEA 2.0’
    Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process
    Nicotinamide Riboside Linked to Cardiovascular Benefits Nicotinamide Riboside Linked to Cardiovascular Benefits
    FDA Launches Dietary Supplement Ingredient Advisory List FDA Launches Dietary Supplement Ingredient Advisory List
    FDA to Hold Public Meeting on ‘Responsible Innovation in Dietary Supplements’ FDA to Hold Public Meeting on ‘Responsible Innovation in Dietary Supplements’
    FDA Commissioner Scott Gottlieb to Resign FDA Commissioner Scott Gottlieb to Resign
    FDA to Hold Meeting on Regulatory Status of CBD in April FDA to Hold Meeting on Regulatory Status of CBD in April
    FDA Plans to Modernize Dietary Supplement Regulations FDA Plans to Modernize Dietary Supplement Regulations
    Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model Study: NR During Breastfeeding Yields Lasting Benefits to Mothers and Offspring in Animal Model
    2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD 2018 Farm Bill Brings Victory for Hemp, Uncertainty for CBD
    ChromaDex ChromaDex

    Related Breaking News

    • Breaking News | Industry & Market News | Quality & Safety

      EAS Assists Food & Hemp Firms with GRAS Submissions

      Firm provides comprehensive services through all phases of the technical GRAS or self-GRAS filing process.
      06.07.19

    • Preparing for FDA’s New Era of Food Safety

      Preparing for FDA’s New Era of Food Safety

      Here are some insights into U.S. regulatory requirements regarding the safety of food and dietary supplements.
      By Gregory Stephens, Windrose Partners, & Sanford W. Bigelow, Vanguard Global Associates LLC 06.03.19

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      Engaging Doctors in the Dialogue About ‘DSHEA 2.0’

      The need for clear and truthful clinical communication should be on the table for discussion as DSHEA goes under review.
      By Erik Goldman, Holistic Primary Care 05.02.19


    • Breaking News | Dietary Supplements | Industry & Market News | Quality & Safety | Regulations | Testing

      Partnership to Help Improve GMP Compliance, GRAS & NDI Application Process

      Alkemist Labs and REJIMUS to help companies fulfill regulatory obligations.
      04.22.19

    • Breaking News | Cardiovascular Health | Research | Research News | Supplier News | Vitamins
      Nicotinamide Riboside Linked to Cardiovascular Benefits

      Nicotinamide Riboside Linked to Cardiovascular Benefits

      The novel form of vitamin B3 helped maintain mitochondrial function in an animal model by stimulating a cellular repair pathway.
      04.17.19

    Loading, Please Wait..
    Breaking News
    • Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    • FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    • MSM Linked to Improvements in Knee Pain
    • Lion’s Mane Extract Linked to Better Cognitive Performance, Subjective Stress
    • NutraShure Introduces SA3X as Exclusive US Supplier
    View Breaking News >
    CURRENT ISSUE

    December 2023

    • State of the Industry Series (Part 1): FDA Restructuring and FTC Activity
    • State of the Industry Part 2: Supplement Access, Safety, and CBD
    • State of the Industry Part 3: Communication, Education, and Trust
    • State of the Industry Part 4: Advanced/Advancing Technologies and Research
    • State of the Industry Part 5: Advocating Best Practices
    • State of the Industry Part 6: Business Trends and Innovation
    • Radicle Science Aims to Set New Trajectory for Healthcare with Modern Clinical Trial Model
    • How Can the Nutraceuticals Industry Empower More Women?
    • The Naturally Proud Network: Supporting Diversity, Equity, and Inclusion
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
    Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
    Peninsula Polymers Acquires New Distribution Center in Indiana
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Dec. 9
    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    Contract Pharma

    Latest Breaking News From Contract Pharma

    FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
    Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
    Innovent Biologics, Synaffix Expand ADC Licensing Deal
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
    Christian Louboutin Taps Morgane Martini as Global Makeup Artist
    Shiseido Forms New Venture Fund
    Happi

    Latest Breaking News From Happi

    Christian Louboutin Names Morgane Martini Global Makeup Artist
    Estée Lauder Lead Scientist Dr. Nadine Pernodet To Lecture At SCC Science Meeting
    Topical Testosterone Formulation for Chest Hair Growth
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
    Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
    BASF Commits to Scope 3.1 Emissions Targets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Carter boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ginni Strikes Deal to Sell Spinning, Knitting Operations
    Campen Machinery Announces Patent Pending Status for Airlaid Trays
    Veocel Partners with Beauty and Feminine Care Brands in Asia Pacific
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Dec. 9
    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
    Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
    Ciena Invests in US Manufacturing with Flex

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login